Sterling Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Sterling Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.2K	Sell	2,724 -19,901	-88%	-$273K	﹤0.01%	1596
2026 Q1	$281K	Sell	22,625 -12,671	-36%	-$170K	0.01%	1013
2025 Q4	$445K	Buy	35,296 +336	+1%	+$3.84K	0.01%	992
2025 Q3	$350K	Buy	34,960 +34,132	+4,122%	+$306K	0.01%	1130
2025 Q2	$6.7K	Buy	828 +249	+43%	+$1.88K	﹤0.01%	2356
2025 Q1	$4.85K	Sell	579 -380	-40%	-$3.17K	﹤0.01%	2181
2024 Q4	$7.59K	Buy	959 +741	+340%	+$6.22K	﹤0.01%	2284
2024 Q3	$1.81K	Buy	+218	New	+$1.71K	﹤0.01%	2227

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sterling Capital Management's AMRX Position: Q2 2026 in Review

Sterling Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 88% in Q2 2026, selling an estimated $273K and leaving 2,724 shares worth $47.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Sterling Capital Management first reported a position in AMRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $445K in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Sterling Capital Management held 2,724 shares of Amneal Pharmaceuticals worth $47.2K as of Q2 2026.
Sterling Capital Management sold 19,901 Amneal Pharmaceuticals shares in Q2 2026, an estimated $273K.
Amneal Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1596 holding.
Sterling Capital Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Amneal Pharmaceuticals position peaked at $445K in Q4 2025.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.